Investment
Features
FeesSafety
Academy
More
Pluang+

The Hanover Insurance earns top spots on TIME and Forbes best companies lists again in 2026

Market News
28 Sep 2026
PRNewsWire
View Source
Bullish
The Hanover Insurance earns top spots on TIME and Forbes best companies lists again in 2026

The Hanover Insurance Group has been recognized on TIME's World's Best Companies list for the fourth year and Forbes' America's Best Insurance Companies list for the sixth year. These honors reflect the company's strong business strategy, excellent customer service, and positive workplace culture. The awards were based on factors like revenue growth, employee satisfaction, sustainability, and customer feedback. The Hanover continues to be a leading property and casualty insurer with over 4,900 employees nationwide.

The Hanover's recognition among TIME's World's Best Companies and Forbes' America's Best Insurance Companies offers context for readers interested in the financial sector. For readers following Financials-sector US stocks on Pluang, 8 out of 85 stocks rose while 77 fell. Notable prices include AFRM at USD 68.63 with a -4.04% change and a typical hold time of 21 days, HUT at USD 92.93 with a -4.02% change and an 11-day hold time, and SOFI at USD 15.94 with a -3.86% change and a 60-day hold time, as of Sep 28, 2026 22:41 WIB.

More News

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals reported a 12% revenue increase to $3.33 billion in Q2, driven by its dominant cystic fibrosis treatments. UBS raised its price target from $585 to $615, reflecting confidence in Vertex's strong financials and growth potential....

Analyst Insights
Bullish
2 hours ago
Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock surged 37.6% recently, driven by rising demand for AI services and new AI-focused offerings. The company outpaced industry growth and secured 100 new clients for advanced AI projects in one quarter. An analyst raised the price targe...

Analyst Insights
Bullish
3 hours ago
SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX, trading near $148 per share with a market cap of about $1.95 trillion, is preparing for Starship's first orbital mission and the deployment of its first operational Starlink V3 satellites. This milestone is key for expanding Starlink's global...

Market News
Bullish
3 hours ago
Kodiak Sciences shares jump 162% after phase III trial success for wet AMD drugs Zenkuda and tabirafusp-ted

Kodiak Sciences shares jump 162% after phase III trial success for wet AMD drugs Zenkuda and tabirafusp-ted

Kodiak Sciences saw its shares surge over 162% after its experimental drugs Zenkuda and tabirafusp-ted met primary endpoints in the phase III DAYBREAK trial for wet age-related macular degeneration (AMD). Both drugs showed vision gains comparable to ...

Company Fundamentals
Bullish
4 hours ago
Bluerock Acquisition Corp. II closes $172.5M IPO, listing on Nasdaq under ticker BRRKU

Bluerock Acquisition Corp. II closes $172.5M IPO, listing on Nasdaq under ticker BRRKU

Bluerock Acquisition Corp. II completed its initial public offering of 17.25 million units at $10 each, raising $172.5 million, including the full exercise of the underwriter's over-allotment option. Each unit includes one Class A share and half a wa...

Others
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App